TNXP

#4997
Tonix Pharmaceuticals Holding Corp. - Common Stock
0.1 2 USD
-2.68%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.12
0.12
Year Range
0.12
17.00
Daily Change
-2.68%
Monthly Change
-99.00%
6 month change
-99.18%
Year Change
-99.18%
Previous Close
0.1 3
Open
0.1 2
Low
0.1 2
High
0.1 2
Volume
35
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.97 M
  • Employee 142
  • Founded 2007
  • CEO Seth Lederman
  • Website www.tonixpharma.com
  • Headquarter Nevada, United States
  • FIGI BBG000LG8XM5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.07
Price to sales ratio
10.14

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

News